Session » Rheumatoid Arthritis-Small Molecules, Biologics and Gene Therapy VI: Strategies
-
Abstract Number: 3194
Oral to Subcutaneous Methotrexate Dose-Conversion Strategies in the Treatment of Rheumatoid Arthritis
-
Abstract Number: 3195
Circulating Micro-RNA Profiles in Responders to Adalimumab Plus Methotrexate Versus Methotrexate Alone: A Placebo-Controlled Clinical Trial
-
Abstract Number: 3196
Predictive Biomarkers for Response or Non-Response to MTX Monotherapy in Early RA
-
Abstract Number: 3197
Clinical Practice Experience in Rheumatoid Arthritis Patients Treated with Triple Therapy and Methotrexate-Tumor Necrosis Factor Inhibition Differs from That of Randomized Controlled Trials